The Pulse on Global Diagnostics: Bill Morice, M.D., Ph.D.

Answers from the Lab

English - February 01, 2024 07:00 - 11 minutes - 15.4 MB
Medicine Health & Fitness Science laboratory medicine healthcare answers from the lab mayo clinic laboratories lab mayo clinic clinical dlmp morice pritt Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Assay stratifies pregnant women's preeclampsia risk: Joshua Bornhorst, Ph.D.

Next Episode: Assay enhances and simplifies M-proteins screening: David Murray, M.D., Ph.D.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss what companies in the healthcare and diagnostics industries are focusing on in 2024.

Their discussion includes:

Insights from the J.P. Morgan Healthcare Conference, and where investments are happening in the diagnostics industry.Observations from visiting Southeast Asia around international healthcare innovation and testing accessibility. The importance of private-public partnerships and investments to advance global health.